Frequency and risk factors of contrast-induced nephropathy after cardiac catheterization in type II diabetic patients: a study among Egyptian patients

References

• McCullough PA, Wolyn R, Rocher LL, Levin RN, O’Neill WW. Acute renal failure after coronary intervention: incidence, risk factors and relationship to mortality. Am J Med. 1997;103:368–375
   PubMed Web of Science ®Google Scholar
• Gruberg L, Mintz GS, Mehran R, et al. The prognostic implications of further renal function deterioration within 48 hours of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol. 2000;36:1542–1548
   PubMed Web of Science ®Google Scholar
• Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004;44:1393–1399
   PubMed Web of Science ®Google Scholar
• McCullough PA. Beyond serum creatinine: defining the patient with renal insufficiency and why? Rev Cardiovasc Med. 2003;4(Suppl 1):S2–S6
   PubMedGoogle Scholar
• Gruberg L, Mehran R, Dangas G, et al. Acute renal failure requiring dialysis after percutaneous coronary interventions. Catheter Cardiovasc Interv. 2001;52:409–416
   PubMed Web of Science ®Google Scholar
• Gruberg L, Mehran R, Dangas G, et al. Acute renal failure requiring dialysis after coronary interventions. Catheter Cardiovasc Interv. 2001;52:417–419
   Google Scholar
• Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004;44:1393–1399
   PubMed Web of Science ®Google Scholar
• Bartholomew BA, Harjai KJ, Dukkipati S, et al. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol. 2004;93:1515–1519
   PubMed Web of Science ®Google Scholar
• Bouzas-Mosquera A, Vázquez-Rodríguez JM, Calviño-Santos R, et al. Contrast induced nephropathy and acute renal failure following emergent cardiac catheterization: incidence, risk factors, and prognosis [in Spanish]. Rev Esp Cardiol. 2007;60:1026–1034
   PubMed Web of Science ®Google Scholar
• Herts BR, Schneider E, Poggio ED, et al. Identifying outpatients with renal insufficiency before contrast-enhanced CT by using estimated glomerular filtration rates versus serum creatinine levels. Radiology. 2008;248:106–113
   Google Scholar
• Maioli M, Toso A, Gallopin M, et al. Preprocedural score for risk of contrast-induced nephropathy in elective coronary angiography and intervention. J Cardiovasc Med (Hagerstown). 2010;11:444–449
   PubMed Web of Science ®Google Scholar
• Schweiger MJ, Chambers CE, Davidson CJ, et al. Prevention of contrast induced nephropathy: recommendation+ns for the high-risk patient undergoing cardiovascular procedures. Catheter Cardiovasc Interv. 2007;69:135–140
   PubMed Web of Science ®Google Scholar
• Ghani AA, Tohamy KY. Risk score for contrast induced nephropathy following percutaneous coronary intervention. Saudi J Kidney Dis Transpl. 2009;202:240–245
   Google Scholar
• Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons; endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol. 2007;50:652–726
   Web of Science ®Google Scholar
• Mangano CM, Diamondstone LS, Ramsay LG, et al. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes and hospital resource utilization. The Multicenter Study of Postoperative Ischemia Research Group. Ann Intern Med. 1998;128:194–203
   PubMed Web of Science ®Google Scholar
• Briguori C, Manganelli F, Scarpato P, et al. Acetylcysteine and contrast agent-associated nephrotoxicity. J Am Coll Cardiol. 2002;40:298–303
   PubMed Web of Science ®Google Scholar
• Mueller C, Buerkle G, Buettner HJ, et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med. 2002;162:329–336
   PubMed Web of Science ®Google Scholar
• Diaz-Sandoval LJ, Kosowsky BD, Losordo DW. Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial). Am J Cardiol. 2002;89:356–358
   PubMed Web of Science ®Google Scholar
• Solomon R. The role of osmolality in the incidence of contrast-induced nephropathy: a systemic review of angiographic contrast media in high risk patients. Kidney Int. 2005;68:2256–2263
   PubMed Web of Science ®Google Scholar
• Marenzi G, Marana I, Lauri G, et al. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N Engl J Med. 2003;349:1333–1340
   PubMed Web of Science ®Google Scholar
• Rossert J, Fouqueray B. Screening and management of patients with early chronic kidney disease. Acta Diabetol. 2004;41:S6–S12
   Google Scholar
• Smith SC, Dove JT, Jacobs AK, et al. ACC/AHA guidelines for percutaneous coronary intervention. Circulation. 2001;103:3019–3041
   PubMed Web of Science ®Google Scholar
• Vlietstra RE, Nunn CM, Narvarte J, et al. Contrast nephropathy after coronary angioplasty in chronic renal insufficiency. Am Heart J. 1996;132:1049–1050
   Google Scholar
• Mason RA, Arbeit LA, Giron F. Renal dysfunction after arteriography. JAMA. 1985;253:1001–1004
   Google Scholar
• McCullough PA, Wolyn R, Rocher LL, et al. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med. 1997;103:368–375
   PubMed Web of Science ®Google Scholar
• Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004;44:1393–1399
   PubMed Web of Science ®Google Scholar
• Manske CL, Sprafka JM, Strony JT, et al. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med. 1990;89:615–620
   PubMed Web of Science ®Google Scholar
• Taliercio CP, Vlietstra RE, Fisher LD, et al. Risks for renal dysfunction with cardiac angiography. Ann Intern Med. 1986;104:501–504
   PubMed Web of Science ®Google Scholar
• Miller DL, Chang R, Wells WT, et al. Intravascular contrast media: effect of dose on renal function. Radiology. 1988;167:607–611
   Google Scholar
• Cruz C, Hricak H, Samhouri F, et al. Contrast media for angiography: effect on renal function. Radiology. 1986;158:109–112
   Google Scholar
• Parfrey PS, Griffiths SM, Barrett BJ, et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med. 1989;320:143–149
   PubMed Web of Science ®Google Scholar
• Roy P, Raya V, Okabe T, et al. Incidence, predictors and outcomes of post-percutaneous coronary intervention nephropathy in patients with diabetes mellitus and normal baseline serum creatinine levels. Am J Cardiol. 2008;101(11):1544–1549
   PubMed Web of Science ®Google Scholar
• Bartholomew BA, Harjai KJ, Dukkipati S, et al. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol. 2004;93(12):1515–1519
   PubMed Web of Science ®Google Scholar
• Solomon R. The role of osmolality in the incidence of contrast-induced nephropathy: a systematic review of angiographic contrast media in high risk patients. Kidney Int. 2005;68(5):2256–2263
   PubMed Web of Science ®Google Scholar
• Marenzi G. La prevenzione della nefropatia da mezzo di contrasto e la gestione del paziente a rischio. G Ital Cardiol. 2009;10:88–96
   Google Scholar
• Gruberg L, Mehran R, Dangas G, et al. Acute renal failure requiring dialysis after coronary interventions. Catheter Cardiovasc Interv. 2001;52:417–419
   Google Scholar
• (a). Chen SL, Zhang J, Yei F, et al. Clinical outcomes of contrast induced nephropathy in patients undergoing percutaneous coronary intervention: a prospective, multicenter, randomized study to analyze the effect of hydration and acetylcysteine. Int J Cardiol. 2008;126:407–413. (b). Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002;105:2259–2264
   Google Scholar
• Rudnick MR, Berns JS, Cohen RM, et al. Nephrotoxic risks of renal angiography: contrast media-associated nephrotoxicity and atheroembolism – a critical review. Am J Kidney Dis. 1994;24(4):713–727
   PubMed Web of Science ®Google Scholar